Director/Sr. Principal Scientist
Simulations Plus, Inc
Westerville, Ohio, United States
Dr. Ryan Suderman is currently Director and Senior Principal Scientist in the quantitative systems pharmacology (QSP) group within Simulations Plus, Inc. His primary work involves QSP modelling for prediction of clinical efficacy in late-stage trials within the auto-immune and immuno-oncology domains. He is also involved in efforts to standardize biological representation and computational methodology within QSP models.
Prior to joining Simulations Plus, Dr. Suderman modelled the dynamics of IgE/FceR1 signaling in mast cells as a postdoctoral fellow at Los Alamos National Laboratory. He earned his Ph.D. in computational biology at the University of Kansas with a focus on information transmission in cellular signaling networks, and received a bachelor of arts in mathematics from Goshen College in Indiana.
Disclosure information not submitted.
Simulations Plus: End-to-end clinical trial modeling with the Thales QSP software platform
Saturday, October 18, 2025
8:00 AM - 5:00 PM MDT
Scaling Peaks Unclimbed: How QSP is Shaping the Future Landscape of MIDD in Diseases Beyond Oncology
Tuesday, October 21, 2025
9:00 AM - 10:30 AM MDT